Matches in SemOpenAlex for { <https://semopenalex.org/work/W1536062932> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W1536062932 endingPage "728" @default.
- W1536062932 startingPage "722" @default.
- W1536062932 abstract "Nishikawa T, Inagaki J, Nagatoshi Y, Fukano R, Nakashima K, Ito N, Sawa D, Kawano Y, Okamura J. The second therapeutic trial for children with hematological malignancies who relapsed after their first allogeneic SCT: Long-term outcomes. Abstract: The impact of a second all-SCT on the long-term outcomes of children who relapse after allo-SCT has been unclear. We retrospectively analyzed the long-term outcomes of different salvage treatments for such children. Sixty-six children with hematological malignancies (40 ALL, 22 AML, three MDS, and one CML) who relapsed after a first allo-SCT received either a second allo-SCT (n = 16) or CTx and/or DLI (n = 50). The median follow-up for all children was 9.1 yr. The five-yr OS after relapse was significantly better in patients who underwent a second allo-SCT (42.9%) than in patients treated with CTx and/or DLI (11.8%) (p < 0.05). However, this advantage diminished with increasing time. The eight-yr OS for these groups of patients were 21.4% and 11.8%, respectively (p = n.s.). Among the 16 patients who received a second allo-SCT, two died more than five yr after the second allo-SCT. A second allo-SCT can therefore lead to a prolonged OS in patients who relapse after allo-SCT. However, a second allo-SCT should be selected carefully. This is because the mortality rate is still high, even when there is an extensive duration of time following the second allo-SCT." @default.
- W1536062932 created "2016-06-24" @default.
- W1536062932 creator A5012115273 @default.
- W1536062932 creator A5014357134 @default.
- W1536062932 creator A5023572058 @default.
- W1536062932 creator A5031398871 @default.
- W1536062932 creator A5044016093 @default.
- W1536062932 creator A5053911733 @default.
- W1536062932 creator A5059362468 @default.
- W1536062932 creator A5068530089 @default.
- W1536062932 creator A5091820922 @default.
- W1536062932 date "2012-06-13" @default.
- W1536062932 modified "2023-09-25" @default.
- W1536062932 title "The second therapeutic trial for children with hematological malignancies who relapsed after their first allogeneic SCT: Long-term outcomes" @default.
- W1536062932 cites W1485790698 @default.
- W1536062932 cites W1707184873 @default.
- W1536062932 cites W1961045948 @default.
- W1536062932 cites W1966050525 @default.
- W1536062932 cites W1996628620 @default.
- W1536062932 cites W2002850871 @default.
- W1536062932 cites W2006011736 @default.
- W1536062932 cites W2021412223 @default.
- W1536062932 cites W2023124698 @default.
- W1536062932 cites W2028757734 @default.
- W1536062932 cites W2033961322 @default.
- W1536062932 cites W2046478477 @default.
- W1536062932 cites W2053271294 @default.
- W1536062932 cites W2068700346 @default.
- W1536062932 cites W2159507916 @default.
- W1536062932 cites W2314153116 @default.
- W1536062932 cites W2322835978 @default.
- W1536062932 doi "https://doi.org/10.1111/j.1399-3046.2012.01737.x" @default.
- W1536062932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22694185" @default.
- W1536062932 hasPublicationYear "2012" @default.
- W1536062932 type Work @default.
- W1536062932 sameAs 1536062932 @default.
- W1536062932 citedByCount "5" @default.
- W1536062932 countsByYear W15360629322014 @default.
- W1536062932 countsByYear W15360629322020 @default.
- W1536062932 countsByYear W15360629322021 @default.
- W1536062932 countsByYear W15360629322022 @default.
- W1536062932 crossrefType "journal-article" @default.
- W1536062932 hasAuthorship W1536062932A5012115273 @default.
- W1536062932 hasAuthorship W1536062932A5014357134 @default.
- W1536062932 hasAuthorship W1536062932A5023572058 @default.
- W1536062932 hasAuthorship W1536062932A5031398871 @default.
- W1536062932 hasAuthorship W1536062932A5044016093 @default.
- W1536062932 hasAuthorship W1536062932A5053911733 @default.
- W1536062932 hasAuthorship W1536062932A5059362468 @default.
- W1536062932 hasAuthorship W1536062932A5068530089 @default.
- W1536062932 hasAuthorship W1536062932A5091820922 @default.
- W1536062932 hasConcept C126322002 @default.
- W1536062932 hasConcept C141071460 @default.
- W1536062932 hasConcept C187212893 @default.
- W1536062932 hasConcept C71924100 @default.
- W1536062932 hasConcept C90924648 @default.
- W1536062932 hasConceptScore W1536062932C126322002 @default.
- W1536062932 hasConceptScore W1536062932C141071460 @default.
- W1536062932 hasConceptScore W1536062932C187212893 @default.
- W1536062932 hasConceptScore W1536062932C71924100 @default.
- W1536062932 hasConceptScore W1536062932C90924648 @default.
- W1536062932 hasIssue "7" @default.
- W1536062932 hasLocation W15360629321 @default.
- W1536062932 hasLocation W15360629322 @default.
- W1536062932 hasOpenAccess W1536062932 @default.
- W1536062932 hasPrimaryLocation W15360629321 @default.
- W1536062932 hasRelatedWork W2002120878 @default.
- W1536062932 hasRelatedWork W2003938723 @default.
- W1536062932 hasRelatedWork W2047967234 @default.
- W1536062932 hasRelatedWork W2118496982 @default.
- W1536062932 hasRelatedWork W2364998975 @default.
- W1536062932 hasRelatedWork W2369162477 @default.
- W1536062932 hasRelatedWork W2439875401 @default.
- W1536062932 hasRelatedWork W4238867864 @default.
- W1536062932 hasRelatedWork W2519357708 @default.
- W1536062932 hasRelatedWork W2525756941 @default.
- W1536062932 hasVolume "16" @default.
- W1536062932 isParatext "false" @default.
- W1536062932 isRetracted "false" @default.
- W1536062932 magId "1536062932" @default.
- W1536062932 workType "article" @default.